OCCURRENCE OF COLLAGEN AND PROTEOGLYCAN FORMS OF TYPE-IX COLLAGEN IN CHICK-EMBRYO CARTILAGE - PRODUCTION AND CHARACTERIZATION OF A COLLAGEN FORM-SPECIFIC ANTIBODY

被引:0
|
作者
YADA, T
ARAI, M
SUZUKI, S
KIMATA, K
机构
[1] AICHI MED UNIV,INST MOLEC SCI MED,NAGAKUTE,AICHI 48011,JAPAN
[2] SEIKAGAKU CORP,TOKYO RES INST,HIGASHIYAMATO 189,JAPAN
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Type IX collagen from chick embryonic cartilage is a proteoglycan bearing a single chondroitin sulfate chain covalently linked to the alpha-2(IX) polypeptide chain. We have isolated type IX collagen metabolically labeled with [H-3]proline using an antibody to type IX collagen and have found that the molecule is synthesized in two forms, a collagen form (COLIX) and a proteoglycan form (PGIX). In cultured chondrocytes, the two forms of type IX collagen showed a different ability to be deposited in the matrix. We have suggested the possibility that both forms may arise from an alternative substitution of a chondroitin sulfate chain to the NC3 domain of the alpha-2(IX) chain. Based on the reported amino acid sequence at the NC3 domain of alpha-2(IX), we have synthesized undecapeptides containing the sequence around the glycosaminoglycan attachment site of the alpha-2(IX) chain. Antibody against the peptide, which was raised in rabbit, only recognized COLIX and made it possible to distinguish COLIX from PGIX. Evidence shows that this could be due to a difference in antigenicity of the NC3 domain of the alpha-2(IX) chain between COLIX and PGIX caused by the substitution of a chondroitin sulfate chain to the serine residue in this domain. Therefore, this antibody may be useful as a probe for studies on the functions of glycosaminoglycan substitution in type IX collagen.
引用
收藏
页码:9391 / 9397
页数:7
相关论文
共 50 条
  • [31] CARTILAGE TYPE-IX COLLAGEN-PROTEOGLYCAN CONTAINS A LARGE AMINOTERMINAL GLOBULAR DOMAIN ENCODED BY MULTIPLE EXONS
    VASIOS, G
    NISHIMURA, I
    KONOMI, H
    VANDERREST, M
    NINOMIYA, Y
    OLSEN, BR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1988, 263 (05) : 2324 - 2329
  • [32] TYPE-IX COLLAGEN GENE-EXPRESSION DURING LIMB CARTILAGE DIFFERENTIATION
    KULYK, WM
    COELHO, CND
    KOSHER, RA
    MATRIX, 1991, 11 (04): : 282 - 288
  • [33] D-PERIODIC DISTRIBUTION OF COLLAGEN TYPE-IX ALONG CARTILAGE FIBRILS
    VAUGHAN, L
    MENDLER, M
    HUBER, S
    BRUCKNER, P
    WINTERHALTER, KH
    IRWIN, MI
    MAYNE, R
    JOURNAL OF CELL BIOLOGY, 1988, 106 (03): : 991 - 997
  • [34] ASSAY OF COLLAGEN-GALACTOSYLTRANSFERASE AND COLLAGEN-GLUCOSYLTRANSFERASE ACTIVITIES AND PRELIMINARY CHARACTERIZATION OF ENZYMIC REACTIONS WITH TRANSFERASES FROM CHICK-EMBRYO CARTILAGE
    MYLLYLA, R
    RISTELI, L
    KIVIRIKKO, KI
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1975, 52 (03): : 401 - 410
  • [35] EXTRACTION AND CHARACTERIZATION OF THE TISSUE FORMS OF COLLAGEN TYPE-II AND TYPE-IX FROM BOVINE VITREOUS
    BISHOP, PN
    CROSSMAN, MV
    MCLEOD, D
    AYAD, S
    BIOCHEMICAL JOURNAL, 1994, 299 : 497 - 505
  • [36] PRODUCTION AND CHARACTERIZATION OF A MONOCLONAL ANTIBODY TO CHICK TYPE-I COLLAGEN
    LINSENMAYER, TF
    LITTLE, CD
    HENDRIX, MJC
    ANATOMICAL RECORD, 1979, 193 (03): : 605 - 605
  • [37] PEPTIDE-SPECIFIC ANTIBODIES IDENTIFY THE ALPHA-2 CHAIN AS THE PROTEOGLYCAN SUBUNIT OF TYPE-IX COLLAGEN
    KONOMI, H
    SEYER, JM
    NINOMIYA, Y
    OLSEN, BR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1986, 261 (15) : 6742 - 6746
  • [38] P-HMW-COLLAGEN, A MINOR COLLAGEN OBTAINED FROM CHICK-EMBRYO CARTILAGE WITHOUT PROTEOLYTIC TREATMENT OF THE TISSUE
    BRUCKNER, P
    MAYNE, R
    TUDERMAN, L
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1983, 136 (02): : 333 - 339
  • [39] PURIFICATION AND CHARACTERIZATION OF THE LOW-MOLECULAR-MASS (TYPE-X) COLLAGEN FROM CHICK-EMBRYO TIBIAL CARTILAGE
    QUARTO, N
    CANCEDDA, R
    DESCALZICANCEDDA, F
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1985, 147 (02): : 397 - 400
  • [40] COLLAGEN PRODUCTION IN-VITRO BY RETINAL PIGMENTED EPITHELIUM OF CHICK-EMBRYO
    NEWSOME, DA
    KENYON, KR
    DEVELOPMENTAL BIOLOGY, 1973, 32 (02) : 387 - 400